Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. [ 3 ] [ 4 ] Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals , focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

  3. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.

  4. Nepafenac - Wikipedia

    en.wikipedia.org/wiki/Nepafenac

    Nepafenac, sold under the brand name Nevanac among others, is a nonsteroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop 0.1% solution (Nevanac) or 0.3% solution (Ilevro). It is used to treat pain and inflammation associated with cataract surgery. [3] Nepafenac is a prodrug of amfenac, an inhibitor of COX-1 and COX-2 ...

  5. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis is the world's first largest in life sciences and agribusiness markets. [6] It is also the second-largest pharmaceutical company by market cap in 2019. [126] Alcon: At the time Novartis bought Alcon, they had annual sales of $6.5 billion and a net income of $2 billion. [127]

  6. Novartis Obtains Final Shares of Alcon for $12.9 Billion - AOL

    www.aol.com/2010/12/15/novartis-obtains-final...

    Shares of Novartis (NVS) soared higher on Wednesday, after the Swiss drug maker finally obtained the remaining outstanding shares of Alcon (ACL) for $12.9 billion. Novartis had been trying to gain ...

  7. Novartis Aims to Beat $1.9B in Cost Savings By Year's End - AOL

    www.aol.com/2011/09/13/novartis-aims-to-beat-19b...

    Novartis (NYS: NVS) has two things to say. It now expects more bang for its buck from Alcon. The eye-care acquisition, which cost Novartis $51 billion, will deliver high single-digit to low double ...

  8. Private Sponsorship of Refugees Program - Wikipedia

    en.wikipedia.org/wiki/Private_Sponsorship_of...

    The Private Sponsorship of Refugees Program ( PSR) is a Canadian government initiative that allows for refugees to resettle in Canada with support and funding from private or joint government-private sponsorship. [1] The government also offers semi-private sponsorship through the Blended Visa Office-Referred ( BVOR) program, which connects ...

  9. Olympic soccer spygate: Canada staffer detained, coach sent ...

    www.aol.com/sports/olympic-soccer-spygate-canada...

    Canada's players walk on the pitch at Geoffroy-Guichard Stadium ahead of the 2024 Summer Olympics, Tuesday, July 23, 2024, in Saint-Etienne, France. Canada is scheduled to play New Zealand on ...